Cutler Group LLC / CA - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 2 filers reported holding BRIACELL THERAPEUTICS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 13.0%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q3 2022$11,000
+450.0%
12,282
+528.2%
0.00%
Q2 2022$2,000
+100.0%
1,955
-51.1%
0.00%
Q1 2022$1,000
-90.0%
4,000
-71.8%
0.00%
Q4 2021$10,00014,2000.00%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 750,000$7,605,0008.16%
K.J. Harrison & Partners Inc 1,351,782$13,749,0002.21%
Redmond Asset Management, LLC 137,942$1,399,0000.42%
SABBY MANAGEMENT, LLC 29,962$304,0000.04%
Concord Wealth Partners 16,775$170,0000.04%
Leonard Green & Partners, L.P. 500,000$5,070,0000.04%
Summit Trail Advisors, LLC 35,000$355,0000.03%
WASATCH ADVISORS LP 244,691$2,481,0000.01%
Apollon Wealth Management, LLC 13,900$141,0000.01%
NATIONAL BANK OF CANADA /FI/ 156,900$1,591,0000.01%
View complete list of BRIACELL THERAPEUTICS CORP shareholders